Screener
Corcept Therapeutics CORT Gross Profit
Discontinued — last reported Q2 '26
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Corcept Therapeutics’s reported figures.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
FAQ
- What is Corcept Therapeutics's gross profit?
- Corcept Therapeutics (CORT) reported gross profit of $252.09M in Q2 2026.
- How has Corcept Therapeutics's gross profit changed year-over-year?
- Corcept Therapeutics's gross profit increased by 32.0% year-over-year, from $191M to $252.09M.
- What is the long-term trend for Corcept Therapeutics's gross profit?
- Over 4 years (2021 to 2025), Corcept Therapeutics's gross profit has grown at a 20.0% compound annual growth rate (CAGR), from $360.7M to $748.43M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Corcept Therapeutics's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude